Analgesics (Non-opioid) & Antipyretics
| Drug | Dosage | Remarks |
|---|---|---|
| Aspirin | 300-900 mg PO 4-6 hourly Max dose: 4 g/day |
Adverse Reactions
|
| Ibuprofen | 200-400 mg PO 4-6 hourly as needed Max dose: 3.2 g/day |
|
| Paracetamol (Acetaminophen) | 325-650 mg PO 4-6 hourly or 1,000 mg PO 6 hourly Max dose: 4 g/day |
Adverse Reactions
|
Antibacterial Combinations
| Drug | Dosage1 | Remarks |
|---|---|---|
| Co-trimoxazole (Sulfamethoxazole [SMZ] and Trimethoprim [TM]) |
800 mg SMZ/160 mg TM PO 12 hourly | Adverse Reactions
|
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Cephalosporins
| Drug | Dosage1 | Remarks |
|---|---|---|
| Second Generation | ||
| Cefaclor | 250-500 mg PO 8 hourly or 750 mg PO 8 hourly Max dose: 4 g/day |
Adverse Reactions
|
| Cefotiam | 200-400 mg PO 12 hourly | |
| Cefprozil | 250-500 mg PO 12 hourly | |
| Cefuroxime | 250 mg PO 12 hourly | |
| Third Generation | ||
| Cefdinir | 300 mg PO 12 hourly or 600 mg PO 24 hourly |
|
| Cefixime | 100 mg PO 12 hourly or 400 mg PO as single dose or divided 12 hourly |
|
| Cefotaxime | 2 g IV 4-6 hourly | |
| Cefpodoxime | 200 mg PO 12 hourly | |
| Ceftibuten | 400 mg PO 24 hourly | |
| Ceftriaxone | 1-2 g IM/IV 12-24 hourly x 5-10 days | |
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Corticosteroid (Intranasal)
| Drug | Available Strength | Dosage | Remarks |
|---|---|---|---|
| Mometasone | 50 mcg/dose nasal spray | 2 sprays each nostril 12 hourly Total dose/day: 400 mcg |
Adverse Reactions
|
Cough & Cold Preparations
| Drug | Dosage | Remarks |
|---|---|---|
| Erdosteine | 300 mg PO 8-12 hourly | Adverse Reactions
|
| Pseudoephedrine1 | 60 mg PO 4-6 hourly | Adverse Reactions
|
| 1Combinations with antihistamines are available. Please see the latest MIMS for specific formulations and prescribing information. | ||
Macrolides
| Drug | Dosage1 | Remarks |
|---|---|---|
| Erythromycin | 250-400 mg PO 6 hourly or 500-800 mg PO 12 hourly |
Adverse Reactions
|
| Midecamycin | 900-1,800 mg/day PO divided 8-12 hourly | |
| Roxithromycin | 150 mg PO 12 hourly or 300 mg PO 24 hourly |
|
| Spiramycin | 6-9 MIU/day PO divided 8-12 hourly | |
| Advanced Macrolides | ||
| Azithromycin | 500 mg PO 24 hourly x 3 days or 500 mg PO 24 hourly x 1 day followed by 250 mg PO 24 hourly x 4 days Extended-release: 2 g PO single dose |
|
| Clarithromycin | 250-500 mg PO 12 hourly x 7-14 days Extended-release: 1 g PO 24 hourly |
|
| Josamycin | 1-2 g PO divided 8-12 hourly | |
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Nasal Decongestants & Other Nasal Preparations*
| Drug | Available Strength | Dosage | Remarks |
|---|---|---|---|
| Oxymetazoline | 0.01% nasal drops | Neonates ≤4 weeks old: 1 drop each nostril 8-12 hourly Infants <1 year old: 1-2 drops each nostril 8-12 hourly |
Adverse Reactions
|
| 0.025% nasal drops, nasal spray | 1-6 years old: 1-2 drops each nostril 8-12 hourly 2-6 years old: 2-3 sprays each nostril 12 hourly |
||
| 0.05% nasal drops, nasal spray | >6 years old and adults: 1-2 drops or 1-2 sprays each nostril 8-12 hourly or 2-3 sprays each nostril 12 hourly |
||
| Xylometazoline | 0.05% nasal drops, nasal spray | 6-11 years old: 1-2 drops or 1-2 sprays each nostril 12-24 hourly | |
| 0.1% nasal drops, nasal spray | ≥12 years old and adults: 2-3 drops or 1-3 sprays each nostril 8-10 hourly | ||
| Other Agents | |||
| Sodium chloride | 0.65% nasal drops, spray | 2-4 drops each nostril 6-8 hourly or as needed or 2 sprays each nostril 6-8 hourly or as needed |
Special Instruction
|
| 0.9% nasal drops, spray | 1-2 drops each nostril as needed or 1-2 sprays each nostril as needed | ||
| In combination with sea water | 1-2 drops each nostril as needed or 1-3 sprays each nostril 8 hourly or as needed |
Special Instruction
|
|
| 2.265 g nasal powder | Dissolve 1 sachet to 250 mL water in squeeze or wash bottle then irrigate each nostril 12 hourly in the morning and at bedtime |
Adverse Reactions
|
|
| *Decongestants combined with corticosteroid or antihistamine are available. Please see the latest MIMS for specific formulations and prescribing information. | |||
Other Antibiotic
| Drug | Dosage1 | Remarks |
|---|---|---|
| Lincosamide | ||
| Clindamycin | 600-1,800 mg/day PO divided 6-12 hourly | Adverse Reactions
|
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Other Drugs Acting on the Respiratory System
| Drug | Dosage1 | Remarks |
|---|---|---|
| Pelargonium sidoides | 1-5 years old: 6.25 mg PO 8 hourly 6-12 years old: 12.5 mg PO 8 hourly or 20 mg PO 12 hourly >12 years old and adults: 20 mg PO 8 hourly |
Adverse Reactions
|
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Penicillins
| Drug | Dosage1 | Remarks |
|---|---|---|
| Aminopenicillins with or without Beta-lactamase Inhibitors | ||
| Amoxicillin (Amoxycillin) | 250-500 mg PO 8 hourly or 750-1,000 mg PO 12 hourly |
Adverse Reactions
|
| Amoxicillin/clavulanic acid (Co-amoxiclav, Amoxicillin/clavulanate) |
625 mg PO 8 hourly or 1,000 mg PO 12 hourly Extended release: 2,000 mg/125 mg PO 12 hourly |
|
| Ampicillin/sulbactam (Sultamicillin) |
375-750 mg PO 12 hourly or 1.5-3 g IM/IV 6-8 hourly or 1.5-12 g IM/IV divided 6-8 hourly Max dose: 12 g/day IM/IV |
|
| Sultamicillin tosylate (Sultamicillin tosilate) | 375-750 mg PO 12 hourly | |
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Quinolones
| Drug | Dosage1 | Remarks |
|---|---|---|
| Respiratory Quinolones | ||
| Ciprofloxacin | 500-750 mg PO 12 hourly or 400 mg IV 12 hourly |
Adverse Reactions
|
| Levofloxacin | 500 mg PO 24 hourly x 10-14 days or 750 mg PO 24 hourly x 5 days |
|
| Moxifloxacin | 400 mg PO 24 hourly | |
| Other Quinolones | ||
| Ofloxacin | 100-200 mg PO 8-12 hourly | |
| Sitafloxacin hydrate | 100 mg PO 12 hourly x 7 days | |
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Tetracyclines
| Drug | Dosage1 | Remarks |
|---|---|---|
| Doxycycline | 100 mg PO 12 hourly or 200 mg PO 24 hourly x 1 day followed by 100 mg PO 24 hourly |
Adverse Reactions
|
| 1Duration of therapy unless otherwise stated: 10-14 days. | ||
Disclaimer
All dosage recommendations are for non-pregnant and non-breastfeeding women, and non-elderly adults with normal renal and hepatic function unless otherwise stated.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
